Table 1. Clinical and laboratory characteristics of the patients and controls
| AS patients (n=55) | Controls (n=33) | P value | |
|---|---|---|---|
| IL-6 (pg/mL) | 18.5 (5-545 | 8.1(4-69) | 0.0001 |
| IFNo(pg/ml) | 0.002 (0.002-1.956) | 0.002 (0.002-0.956) | 0.5 |
| BAP (U/L) | 29 (13-107) | 26 (2-51) | 0.1 |
| Calcium (mg/dl) | 10 (9-11) | 9.9 (9,3-11) | 0.6 |
| Phosphor (mg/dl) | 1.3 (1.7-4.7) | 3.4 (2,2-4,5) | 0.9 |
| Vitamin D (nM) | 87 (4-266) | 102 (10-303) | 0.5 |
| NTX (nM BCE) | 82 (52-188) | 84 (57-106) | 0.3 |
| TRAP(U/L) | 3.76 (2.25-6.55) | 3.66 (2.31-8.34) | 0.3 |
| PTH (pg/mL) | 45 (44-170) | 77 (45-180) | 0.01 |
| RANKL (pmol/L) | 284 (101-1598) | 292 (143-783) | 0.7 |
| OPG (pg/mL) | 339 (52-1118) | 527(16-1030) | 0.02 |
| Sklerostin (pmol/L) | 73 (48-126) | 77.1 (49-110) | 0.1 |
| sFrp1 (ng/ml) | 0.1 (0-17) | 0.2 (0-1) | 0.3 |
| DKK1(pg/mL) | 97 (17-771) | 115 (29-278) | 0.6 |